Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dentsply's Degussa Dental Purchase Small Enough To Avoid FTC Challenge

This article was originally published in The Gray Sheet

Executive Summary

Dentsply International's acquisition of Degussa Dental for about $500 mil. in cash will combine the first and second largest suppliers in the worldwide professional dental products market, but the deal is small enough to elude antitrust scrutiny, Dentsply says.

You may also be interested in...



Sulzer Buys Paragon Anticipating Increased Conversion To Dental Implants

Anticipating increased conversion of the tooth replacement market to dental implants from conventional treatments such as bridges and crowns, Sulzer Medica is paying about 3.3 times sales to acquire dental implant maker Core Vent Corporation/Paragon Implant Company. The move roughly doubles Sulzer's share of the $550 mil. dental implant market to about 10.5%.

Dentsply Distribution Practices Violate Antitrust Laws, Justice Says

Dentsply's distribution policies for its Trubyte line of artifical teeth violate U.S. antitrust laws, the Justice Department maintains in a complaint filed Jan. 5 in Delaware federal court.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014951

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel